Cargando…
Intracranial radiotherapy with or without immune checkpoint inhibition for brain metastases: a systematic review and meta-analysis
BACKGROUND: With the development of immunotherapy in recent years, the prognosis of patients is expected to improve due to immune checkpoint inhibition (ICI) combined with radiotherapy (RT). However, studies on combination therapy (ICI + intracranial RT) have reported inconsistent results, and it is...
Autores principales: | He, Qian, Zhang, Chi, Tang, Sheng, Li, Jiayi, Ren, Qinglan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797322/ https://www.ncbi.nlm.nih.gov/pubmed/35117204 http://dx.doi.org/10.21037/tcr-20-902 |
Ejemplares similares
-
The efficacy and safety of immune checkpoint inhibitors combined with antiangiogenic drugs in renal cell carcinomas: a systematic review and meta-analysis
por: He, Qian, et al.
Publicado: (2020) -
Immune Checkpoint Inhibitor with or without Radiotherapy in Melanoma Patients with Brain Metastases: A Systematic Review and Meta-Analysis
por: Kim, Pyeong Hwa, et al.
Publicado: (2021) -
Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors
por: Matsui, Jennifer K., et al.
Publicado: (2022) -
Immune Checkpoint Inhibitors with or without Radiotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Systematic Review and Meta-Analysis
por: Kim, Dong Yeong, et al.
Publicado: (2020) -
Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition
por: Blake, Zoë, et al.
Publicado: (2018)